ストックスクリーナーアプリを入手
1.878
2.09%
-0.032
前日終値:
$1.91
開ける：
$1.93
24時間の取引高:
2.04M
Relative Volume:
0.45
時価総額：
$84.84M
収益：
-
当期純損益:
$-51.50M
株価収益率:
-0.4695
EPS:
-4
ネットキャッシュフロー:
$-47.10M
1週間 パフォーマンス:
+46.09%
1か月 パフォーマンス:
+42.75%
6か月 パフォーマンス:
+6.25%
1年 パフォーマンス:
-64.24%
1日の値動き範囲:
$1.84
$1.99
1週間の範囲:
$1.36
$2.01
52週間の値動き範囲:
$0.79
$5.44
Outlook Therapeutics Inc Stock (OTLK) Company Profile
名前
Outlook Therapeutics Inc
セクター
電話
(609) 619-3990
住所
111 S. WOOD AVENUE, ISELIN, NJ
OTLK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OTLK
Outlook Therapeutics Inc
|
1.88 | 84.84M | 0 | -51.50M | -47.10M | -4.00 |
|
ARGX
Argen X Se Adr
|
917.15 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
202.77 | 43.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.80 | 110.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
ONC
Beone Medicines Ltd Adr
|
356.02 | 40.27B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
705.66 | 76.23B | 14.25B | 4.58B | 3.88B | 41.77 |
Outlook Therapeutics Inc Stock (OTLK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-08-28 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-12-02 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2024-03-27 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-02-15 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2024-01-25 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-12-27 | アップグレード | CapitalOne | Equal Weight → Overweight |
| 2023-08-31 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2023-08-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-08-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-08-30 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-08-30 | ダウングレード | CapitalOne | Overweight → Equal Weight |
| 2023-08-30 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-07-13 | 開始されました | CapitalOne | Overweight |
| 2023-04-03 | 開始されました | Guggenheim | Buy |
| 2023-02-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-10-31 | 開始されました | BTIG Research | Buy |
| 2022-09-13 | 開始されました | Chardan Capital Markets | Buy |
| 2019-09-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2019-05-16 | 開始されました | Oppenheimer | Outperform |
| 2019-04-22 | 開始されました | Ascendiant Capital Markets | Buy |
すべてを表示
Outlook Therapeutics Inc (OTLK) 最新ニュース
What analyst consensus implies for Outlook Therapeutics Inc. (41O) stock2025 Institutional Moves & Breakout Confirmation Alerts - newser.com
Will Outlook Therapeutics Inc. (41ON) stock enhance shareholder valueJobs Report & Verified Momentum Stock Ideas - newser.com
Why Outlook Therapeutics Inc. stock is a must watch in 20252025 Earnings Impact & Weekly Market Pulse Updates - newser.com
Will Outlook Therapeutics Inc. (41O) stock beat value stocksMarket Movers & Accurate Buy Signal Notifications - newser.com
Outlook Therapeutics Shares Surge on Key FDA Regulatory Milestone - Ad-hoc-news.de
Is Outlook Therapeutics Inc. stock a smart buy before Fed meetingMarket Risk Analysis & Fast Moving Trade Plans - newser.com
How Outlook Therapeutics Inc. (41O) stock trades under stagflationWeekly Trade Review & Trade Opportunity Analysis Reports - newser.com
Is Outlook Therapeutics Inc. (41ON) stock expanding market penetrationGold Moves & Real-Time Price Movement Reports - newser.com
Is Outlook Therapeutics Inc. (41ON) stock worth buying before Fed actionJuly 2025 Levels & Accurate Intraday Trading Signals - newser.com
Is Outlook Therapeutics Inc. stock a dividend growth opportunity2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Is Outlook Therapeutics Inc. (41ON) stock cheap vs fundamentals2025 Market Overview & Weekly Market Pulse Updates - newser.com
How Outlook Therapeutics Inc. stock reacts to Fed rate cuts2025 Pullback Review & Risk Managed Trade Strategies - newser.com
Outlook Therapeutics Inc. stock momentum explainedEarnings Recap Report & Smart Money Movement Tracker - newser.com
Outlook Therapeutics Inc. (OTLK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Outlook Therapeutics Surges as FDA Greenlights ONS-5010 Resubmission - timothysykes.com
What technical models suggest about Outlook Therapeutics Inc.’s comeback - newser.com
How to interpret RSI for Outlook Therapeutics Inc. stockPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Is Outlook Therapeutics Inc. stock cheap at current valuationTrend Reversal & Daily Volume Surge Signals - newser.com
FDA Acceptance Boosts Outlook Therapeutics Shares Significantly - timothysykes.com
Biotech Investor Alert: Outlook Therapeutics Nears Critical FDA Verdict - AD HOC NEWS
H.C. Wainwright Sticks to Its Hold Rating for Outlook Therapeutics (OTLK) - The Globe and Mail
FDA Accepts Outlook Therapeutics’ Resubmission for Eye Drug, Stock Surges - StocksToTrade
FDA Accepts Outlook Therapeutics’ BLA Resubmission for ONS-5010 - timothysykes.com
Outlook Therapeutics Inc (OTLK) 財務データ
収益
当期純利益
現金流量
EPS
0.13%
1.36%
大文字化:
|
ボリューム (24 時間):